About Anthony

Hello, I'm Anthony. My mission is to engineer scientific discovery into accessible treatments and meaningful outcomes for patients.

In undergrad, I studied how drugs are developed and brought to market. The gap between the two was often the topic of conversation. My professors would call it the "valley of death," where good science goes to die for lack of what comes after: capital, protection, delivery.

I'd like to bridge that divide.

2019 - 2024

USC
Bachelor of Science (B.S.) in Biopharmaceutical Sciences

2023 - 2026

Clinical Research
Full-time at Cedars-Sinai, UCSF, and Metaclipse Therapeutics

2026 - 2027

Cornell
Master of Engineering (M.Eng.) in Biomedical Engineering

2028 and beyond

JD
Life Sciences Intellectual Property

Interests

- Solid Tumor Oncology
  - Head and Neck Cancer (HNSCC)
  - Non-Small Cell Lung Cancer (NSCLC)
  - Breast Cancer (TNBC, HR+)
  - Ovarian Cancer
  - Brain Cancer
  - Prostate Cancer
  - Colorectal Cancer
- Benign Gynecologic Disease
  - Endometriosis
  - Adenomyosis
  - Fibroids
- Infectious Disease
  - Human Immunodeficiency Virus (HIV)
  - Human Papillomavirus (HPV)
- Cell & Gene Therapy
- Precision Medicine
- Antibody-Drug Conjugates (targeted cancer drugs delivered directly to tumor cells)
- Companion Diagnostics (tests that identify which patients a treatment will work for)
- HIV Advocacy
- Clinical Trial Accessibility
- Drug Pricing & Affordability
- Market Access Strategy (getting approved drugs to patients and payers)
- Real-World Evidence (data from patient outcomes outside clinical trials)